Barriers and facilitators to representative acute leukemia trial participation at National Cancer Institute-designated comprehensive cancer centers.
Saved in:
| Title: | Barriers and facilitators to representative acute leukemia trial participation at National Cancer Institute-designated comprehensive cancer centers. |
|---|---|
| Authors: | Hantel A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, United States.; Harvard Medical School, Boston, MA 02115, United States.; HMS Center for Bioethics, Boston, MA 02115, United States., Blackstone EC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, United States.; HMS Center for Bioethics, Boston, MA 02115, United States., Revette AC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, United States., Roberts JE; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, United States., Mims AS; The Ohio State University, Columbus, OH 43210, United States., DeAngelo DJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, United States.; Harvard Medical School, Boston, MA 02115, United States., Lathan CS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, United States.; Harvard Medical School, Boston, MA 02115, United States., Abel GA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, United States.; Harvard Medical School, Boston, MA 02115, United States.; HMS Center for Bioethics, Boston, MA 02115, United States. |
| Source: | The oncologist [Oncologist] 2025 Sep 01; Vol. 30 (9). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40795379 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Barriers and facilitators to representative acute leukemia trial participation at National Cancer Institute-designated comprehensive cancer centers. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Hantel+A%22">Hantel A</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, United States.; Harvard Medical School, Boston, MA 02115, United States.; HMS Center for Bioethics, Boston, MA 02115, United States.<br /><searchLink fieldCode="AU" term="%22Blackstone+EC%22">Blackstone EC</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, United States.; HMS Center for Bioethics, Boston, MA 02115, United States.<br /><searchLink fieldCode="AU" term="%22Revette+AC%22">Revette AC</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, United States.<br /><searchLink fieldCode="AU" term="%22Roberts+JE%22">Roberts JE</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, United States.<br /><searchLink fieldCode="AU" term="%22Mims+AS%22">Mims AS</searchLink>; The Ohio State University, Columbus, OH 43210, United States.<br /><searchLink fieldCode="AU" term="%22DeAngelo+DJ%22">DeAngelo DJ</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, United States.; Harvard Medical School, Boston, MA 02115, United States.<br /><searchLink fieldCode="AU" term="%22Lathan+CS%22">Lathan CS</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, United States.; Harvard Medical School, Boston, MA 02115, United States.<br /><searchLink fieldCode="AU" term="%22Abel+GA%22">Abel GA</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, United States.; Harvard Medical School, Boston, MA 02115, United States.; HMS Center for Bioethics, Boston, MA 02115, United States. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229607837%22">The oncologist</searchLink> [Oncologist] 2025 Sep 01; Vol. 30 (9). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9607837 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1549-490X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210837159%22">10837159 </searchLink><i>NLM ISO Abbreviation: </i>Oncologist <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40795379 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1093/oncolo/oyaf241 Languages: – Code: eng Text: English Titles: – TitleFull: Barriers and facilitators to representative acute leukemia trial participation at National Cancer Institute-designated comprehensive cancer centers. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Hantel A – PersonEntity: Name: NameFull: Blackstone EC – PersonEntity: Name: NameFull: Revette AC – PersonEntity: Name: NameFull: Roberts JE – PersonEntity: Name: NameFull: Mims AS – PersonEntity: Name: NameFull: DeAngelo DJ – PersonEntity: Name: NameFull: Lathan CS – PersonEntity: Name: NameFull: Abel GA IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 09 Text: 2025 Sep 01 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1549-490X Numbering: – Type: volume Value: 30 – Type: issue Value: 9 Titles: – TitleFull: The oncologist Type: main |
| ResultId | 1 |